O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying
Lanhua Zhao,1,2 Zhe Zhu,1 Lei Ma,1 Yingbo Li1 1Institute of Medical Biology, Chinese Academy of Medical Sciences, Peking Union Medical College, Kunming 650118, People’s Republic of China; 2Institute of Pathogenic Biology, School of Medicine, University of South China, Hengyang, 421001, Peo...
Main Authors: | Zhao L, Zhu Z, Ma L, Li Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-03-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/ow-nanoemulsion-as-an-adjuvant-for-an-inactivated-h3n2-influenza-vacci-peer-reviewed-article-IJN |
Similar Items
-
Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021-01-01) -
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
by: Andris Kazaks, et al.
Published: (2017-11-01) -
Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
by: Lu Lu, et al.
Published: (2020-12-01) -
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
by: Saranya Sridhar, et al.
Published: (2015-04-01) -
Tailored influenza virus vaccines for both the young and old: Vaccine Efficacy of Whole Inactivated Vaccines bearing Immunomodulatory Adjuvants or Multimeric peptides
by: Khan, Tila
Published: (2017)